HOUSTON AMERICAN ENERGY CORP (HUSA)

US44183U2096 - Common Stock

1.46  +0.04 (+2.82%)

After market: 1.44 -0.02 (-1.37%)

Fundamental Rating

2

Taking everything into account, HUSA scores 2 out of 10 in our fundamental rating. HUSA was compared to 204 industry peers in the Oil, Gas & Consumable Fuels industry. HUSA has a great financial health rating, but its profitability evaluates not so good. HUSA is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

HUSA had negative earnings in the past year.
In the past year HUSA had a positive cash flow from operations.
In the past 5 years HUSA always reported negative net income.
In the past 5 years HUSA reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -30.00%, HUSA is doing worse than 96.55% of the companies in the same industry.
The Return On Equity of HUSA (-31.34%) is worse than 90.15% of its industry peers.
Industry RankSector Rank
ROA -30%
ROE -31.34%
ROIC N/A
ROA(3y)-15.71%
ROA(5y)-29.69%
ROE(3y)-16.31%
ROE(5y)-32.47%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HUSA's Gross Margin of 9.52% is on the low side compared to the rest of the industry. HUSA is outperformed by 74.38% of its industry peers.
In the last couple of years the Gross Margin of HUSA has declined.
HUSA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.91%
GM growth 5Y-7.96%

8

2. Health

2.1 Basic Checks

HUSA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HUSA has more shares outstanding
HUSA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for HUSA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

HUSA has an Altman-Z score of 14.70. This indicates that HUSA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 14.70, HUSA belongs to the best of the industry, outperforming 95.07% of the companies in the same industry.
HUSA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.7
ROIC/WACCN/A
WACC9.05%

2.3 Liquidity

HUSA has a Current Ratio of 10.05. This indicates that HUSA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 10.05, HUSA belongs to the top of the industry, outperforming 94.58% of the companies in the same industry.
A Quick Ratio of 10.05 indicates that HUSA has no problem at all paying its short term obligations.
HUSA's Quick ratio of 10.05 is amongst the best of the industry. HUSA outperforms 94.58% of its industry peers.
Industry RankSector Rank
Current Ratio 10.05
Quick Ratio 10.05

0

3. Growth

3.1 Past

HUSA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -257.63%.
HUSA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -47.19%.
Measured over the past years, HUSA shows a very negative growth in Revenue. The Revenue has been decreasing by -19.58% on average per year.
EPS 1Y (TTM)-257.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.77%
Revenue 1Y (TTM)-47.19%
Revenue growth 3Y13.02%
Revenue growth 5Y-19.58%
Sales Q2Q%-42.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

HUSA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

HUSA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 33.47
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

HUSA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HOUSTON AMERICAN ENERGY CORP

NYSEARCA:HUSA (11/22/2024, 4:27:45 PM)

After market: 1.44 -0.02 (-1.37%)

1.46

+0.04 (+2.82%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.11M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30%
ROE -31.34%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 9.52%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 10.05
Quick Ratio 10.05
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-257.63%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-47.19%
Revenue growth 3Y13.02%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y